(Q46965412)

English

Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study

scientific article published in October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

author name string

Henry R Black

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

George L Bakris

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Michael A Weber

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Robert Weiss

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Mahfouz El Shahawy

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Richard Marple

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Georges Tannoury

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Stuart Linas

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Jennifer V Linseman

10

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Robert Roden

11

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Michael J Gerber

12

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

publication date

1 October 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

10

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

760-769

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Calcium channel blockers in the treatment of hypertension and prevention of cardiovascular disease: results from major clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Clinical practice. Resistant or difficult-to-control hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Goal-oriented hypertension management: translating clinical trials to practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Resistant hypertension revisited: a comparison of two university-based cohorts.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

New and emerging pharmacologic strategies in the management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Increased plasma levels of endothelin in diabetic patients with hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Treatment of cardiovascular and renal risk factors in the diabetic hypertensive

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Cardiovascular risk in chronic renal disease and transplantation prevention and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Guidelines for hypertension: are quality-assurance measures on target?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Sitaxsentan therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.07244.X

21 January 2018

Identifiers

10.1111/J.1524-6175.2007.07244.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

release_v7ie7kbrk5g2ba3vef525l5gsy

1 reference

https://api.fatcat.wiki/v0/release/v7ie7kbrk5g2ba3vef525l5gsy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/v7ie7kbrk5g2ba3vef525l5gsy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17917503

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46965412&oldid=2140103804"